Abstract

BackgroundIn general, autosomal dominant inherited hearing loss does not have a founder mutation, with the causative mutation different in each family. For this reason, there has been a strong need for efficient diagnosis methods for autosomal dominant sensorineural hearing loss (ADSNHL) patients. This study sought to verify the effectiveness of our analysis algorithm for the screening of ADSNHL patients as well as the usefulness of the massively parallel DNA sequencing (MPS).Subjects and MethodsSeventy-five Japanese ADSNHL patients from 53 ENT departments nationwide participated in this study. We conducted genetic analysis of 75 ADSNHL patients using the Invader assay, TaqMan genotyping assay and MPS-based genetic screening.ResultsA total of 46 (61.3%) ADSNHL patients were found to have at least one candidate gene variant.ConclusionWe were able to achieve a high mutation detection rate through the combination of the Invader assay, TaqMan genotyping assay and MPS. MPS could be used to successfully identify mutations in rare deafness genes.

Highlights

  • Hearing loss is one of the most frequent congenital disorders in infants, with one out of every 500 newborns having bilateral hearing loss[1]

  • While the invader assay and TaqMan genotyping assay can effectively detect the variants frequently found in Japanese patients based on the large data set of the Japanese hearing loss patients[4], massively parallel DNA sequencing (MPS) can further analyze a large number of genes comprehensively

  • Seventy-five Japanese autosomal dominant sensorineural hearing loss (ADSNHL) patients from 53 ear nose throat (ENT) departments nationwide participated in this study

Read more

Summary

Background

Autosomal dominant inherited hearing loss does not have a founder mutation, with the causative mutation different in each family. For this reason, there has been a strong need for efficient diagnosis methods for autosomal dominant sensorineural hearing loss (ADSNHL) patients. This study sought to verify the effectiveness of our analysis algorithm for the screening of ADSNHL patients as well as the usefulness of the massively parallel DNA sequencing (MPS)

Subjects and Methods
Introduction
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call